Diseases /
Testicular Embryonal Carcinoma
Overview
NCI Definition: A malignant germ cell neoplasm arising from the testis. It is composed of primitive epithelial cells arranged in solid, papillary, and glandular configurations. Most patients present with a testicular mass, which may be associated with pain. More than half of the patients have metastatic disease at diagnosis. The form of treatment following radical orchiectomy is stage dependent. [1]
Testicular embryonal carcinomas most frequently harbor alterations in ETV6, CDKN1B, CCND2, RAD52, and KDM5A [2].
CDKN1B Amplification, CCND2 Amplification, ETV6 Amplification, RAD52 Amplification, and KDM5A Amplification are the most common alterations in testicular embryonal carcinoma [2].
Clinical Trials
Disease Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.